Sulfatide Is Required for Efficient Replication of Influenza A Virus
Open Access
- 15 June 2008
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (12), 5940-5950
- https://doi.org/10.1128/jvi.02496-07
Abstract
Sulfatide is abundantly expressed in various mammalian organs, including the intestines and trachea, in which influenza A viruses (IAVs) replicate. However, the function of sulfatide in IAV infection remains unknown. Sulfatide is synthesized by two transferases, ceramide galactosyltransferase (CGT) and cerebroside sulfotransferase (CST), and is degraded by arylsulfatase A (ASA). In this study, we demonstrated that sulfatide enhanced IAV replication through efficient translocation of the newly synthesized IAV nucleoprotein (NP) from the nucleus to the cytoplasm, by using genetically produced cells in which sulfatide expression was down-regulated by RNA interference against CST mRNA or overexpression of the ASA gene and in which sulfatide expression was up-regulated by overexpression of both the CST and CGT genes. Treatment of IAV-infected cells with an antisulfatide monoclonal antibody (MAb) or an anti-hemagglutinin (HA) MAb, which blocks the binding of IAV and sulfatide, resulted in a significant reduction in IAV replication and accumulation of the viral NP in the nucleus. Furthermore, antisulfatide MAb protected mice against lethal challenge with pathogenic influenza A/WSN/33 (H1N1) virus. These results indicate that association of sulfatide with HA delivered to the cell surface induces translocation of the newly synthesized IAV ribonucleoprotein complexes from the nucleus to the cytoplasm. Our findings provide new insights into IAV replication and suggest new therapeutic strategies.This publication has 44 references indexed in Scilit:
- Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistanceProceedings of the National Academy of Sciences of the United States of America, 2007
- Isolation and identification of nine sulfated glycosphingolipids containing two unique sulfated gangliosides from the African green monkey kidney cells, Verots S3, and their possible metabolic pathwaysGlycobiology, 2006
- Assembly and budding of influenza virusVirus Research, 2004
- Specific downregulation and mistargeting of the lipid raft-associated protein MAL in a glycolipid storage disorderNeurobiology of Disease, 2004
- Recognition of Arylsulfatase A and B by the UDP-N-acetylglucosamine:lysosomal Enzyme N-Acetylglucosamine-phosphotransferaseOnline Journal of Public Health Informatics, 2003
- Cloning, Characterization, and Expression of Human Ceramide Galactosyltransferase cDNABiochemical and Biophysical Research Communications, 1997
- Inhibitory action of sulfatide, a putative ligand for L-selectin, on B cell proliferation and Ig productionInternational Immunology, 1996
- Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits importCell, 1991
- Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophyBiochemical and Biophysical Research Communications, 1990
- Molecular cloning of the sphingolipid activator protein — 1 (SAP - 1), the sulfatide sulfatase activatorBiochemical and Biophysical Research Communications, 1986